摘要
目的现将小儿肺炎支原体肺炎疾病采用阿奇霉素序贯联合痰热清治疗临床效果进行研究。方法随机选取我院儿科2018年2月至2020年2月收治的小儿肺炎支原体肺炎患儿56例,依据随机数字表法对所有患儿进行分组治疗,其中分成对照组与观察组,每组患儿28例,对照组患儿治疗采用单独阿奇霉素,观察组患儿给予阿奇霉素序贯联合痰热清治疗,将两组最终治疗效果进行对比。结果治疗后观察组患儿明显提高了临床治疗效果,加快了临床症状改善速度,且治疗期间发生的不良反应也较少,组间指标数据差异值已达到统计学意义标准(P<0.05)。结论对小儿肺炎支原体肺炎患儿及时采用阿奇霉素序贯与痰热清联合治疗方案进行治疗,能够获得较为理想的治疗效果,且用药安全性也较高,因此能够尽快改善患儿的临床症状。
Objective To study clinical effect of azithromycin sequential combined with Tanreqing in treatment of children with Mycoplasma pneumoniae pneumonia.Methods We chose 56 cases of Mycoplasma pneumoniae pneumonia children admitted to department of pediatrics in our hospital from February 2018 to February 2020,divided them into control group and observation group randomly according to random number table method,28 cases in each group.Control group was treated with azithromycin only,and observation group with azithromycin sequentially combined with Tanreqing.Compare final treatment effect between two groups.Results After treatment,clinical treatment effect of observation group was significantly improved,clinical symptoms improved faster with fewer adverse reactions during treatment.Difference in index data between groups reached standard of statistical significance(P<0.05).Conclusion Combined treatment of azithromycin sequential and tanreqing can achieve relatively ideal curative effect on children with mycoplasma pneumoniae pneumonia,with higer drug safety,improve clinical symptoms as soon as possible of children.
作者
尤凤妍
YOU Feng-yan(Weifang Sunshine Ronghe Hospital,Weifang,Shandong,261000)
出处
《智慧健康》
2020年第30期192-193,共2页
Smart Healthcare
